Jiang X - Search Results

1

Plasma sPD-L1 and VEGF levels are associated with the prognosis of NSCLC patients treated with combination immunotherapy.

Dong C, Hui K, Gu J, Wang M, Hu C, Jiang X. Dong C, et al. Among authors: jiang x. Anticancer Drugs. 2024 Jun 1;35(5):418-425. doi: 10.1097/CAD.0000000000001576. Epub 2024 Feb 23. Anticancer Drugs. 2024. PMID: 38386011

2

Role of NRP-1 in VEGF-VEGFR2-Independent Tumorigenesis.

Hu C, Jiang X. Hu C, et al. Among authors: jiang x. Target Oncol. 2016 Aug;11(4):501-5. doi: 10.1007/s11523-016-0422-0. Target Oncol. 2016. PMID: 26916409 Review.

3

The effect of anti-angiogenic drugs on regulatory T cells in the tumor microenvironment.

Hu C, Jiang X. Hu C, et al. Among authors: jiang x. Biomed Pharmacother. 2017 Apr;88:134-137. doi: 10.1016/j.biopha.2017.01.051. Epub 2017 Jan 16. Biomed Pharmacother. 2017. PMID: 28103506 Review.

4

Apatinib Combined with Local Irradiation Leads to Systemic Tumor Control via Reversal of Immunosuppressive Tumor Microenvironment in Lung Cancer.

Liang LJ, Hu CX, Wen YX, Geng XW, Chen T, Gu GQ, Wang L, Xia YY, Liu Y, Fei JY, Dong J, Zhao FH, Ahongjiang Y, Hui KY, Jiang XD. Liang LJ, et al. Cancer Res Treat. 2020 Apr;52(2):406-418. doi: 10.4143/crt.2019.296. Epub 2019 Sep 3. Cancer Res Treat. 2020. PMID: 31476848 Free PMC article.

5

The role of plasma exosomal lnc-SNAPC5-3:4 in monitoring the efficacy of anlotinib in the treatment of advanced non-small cell lung cancer.

Liu C, Hu C, Chen T, Jiang Y, Zhang X, Liu H, Wang Y, Li Z, Hui K, Jiang X. Liu C, et al. Among authors: jiang x, jiang y. J Cancer Res Clin Oncol. 2022 Oct;148(10):2867-2879. doi: 10.1007/s00432-022-04071-5. Epub 2022 Jun 7. J Cancer Res Clin Oncol. 2022. PMID: 35672525 Clinical Trial.

6

Long noncoding RNA lnc-SNAPC5-3:4 inhibits malignancy by directly upregulating miR-224-3p in non-small cell lung cancer.

Hu C, Wu S, Sun W, Li J, Hui K, Jiang X. Hu C, et al. Among authors: jiang x. Heliyon. 2024 Jan 13;10(2):e24668. doi: 10.1016/j.heliyon.2024.e24668. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38312596 Free PMC article.

7

VEGFR affects miR-3200-3p-mediated regulatory T cell senescence in tumour-derived exosomes in non-small cell lung cancer.

Hui K, Dong C, Hu C, Li J, Yan D, Jiang X. Hui K, et al. Among authors: jiang x. Funct Integr Genomics. 2024 Feb 16;24(2):31. doi: 10.1007/s10142-024-01305-2. Funct Integr Genomics. 2024. PMID: 38363405

8

Case report: Envafolimab combined with Endostar in the treatment of advanced non-small cell lung cancer with malignant pleural effusion.

Dong C, Hu C, Jiang Y, Hui K, Jiang X. Dong C, et al. Among authors: jiang x, jiang y. Front Oncol. 2024 Apr 4;14:1368059. doi: 10.3389/fonc.2024.1368059. eCollection 2024. Front Oncol. 2024. PMID: 38638859 Free PMC article.

9

Non-immune functions of B7-H3: bridging tumor cells and the tumor vasculature.

Wu S, Hu C, Hui K, Jiang X. Wu S, et al. Among authors: jiang x. Front Oncol. 2024 Jun 17;14:1408051. doi: 10.3389/fonc.2024.1408051. eCollection 2024. Front Oncol. 2024. PMID: 38952550 Free PMC article. Review.

10

Case report: Combination therapy of envafolimab with endostar for advanced non-small cell lung cancer with low PD-L1 expression.

Wu S, Dong C, Hu C, Hui K, Jiang X. Wu S, et al. Among authors: jiang x. Front Oncol. 2024 Nov 7;14:1437260. doi: 10.3389/fonc.2024.1437260. eCollection 2024. Front Oncol. 2024. PMID: 39575420 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,744 results

Search Page

Filters